Ranked #3,450 of 8,699 institutional investors
Foresite Capital Management VI LLC
West Hollywood, CA
$542M
US stock portfolio at live prices · today −$75K (−0.01%)
Live prices, last trade 11:05 AM ET
- Value at quarter end (Q3 2026)
- $566M
- Change from Q2 2026
- −$76.2M (−11.86%)
- Positions
- 19 · 3 new, 2 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$33.0M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesCGON 31.8%KRSA 9.90%SPTX 6.05%DNLI 5.57%LTGO 5.30%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| CGON CG Oncology, Inc. | 2,109,574 | $173M | 31.8% | Reduced −11% |
| KRSA Korsana Biosciences, Inc. | 1,431,660 | $53.6M | 9.90% | New |
| SPTX Seaport Therapeutics, Inc. | 1,779,521 | $32.8M | 6.05% | Unchanged |
| DNLI Denali Therapeutics Inc. | 1,617,771 | $30.2M | 5.57% | Added +16% |
| LTGO Latigo Biotherapeutics, Inc. | 2,203,800 | $28.7M | 5.30% | New |
| PBLS Parabilis Medicines, Inc. | 999,044 | $27.9M | 5.14% | Unchanged |
| AGIO Agios Pharmaceuticals, Inc. | 827,128 | $23.6M | 4.35% | Added +5% |
| VSTM Verastem, Inc. | 3,146,631 | $20.7M | 3.82% | Unchanged |
| CRVS Corvus Pharmaceuticals, Inc. | 1,831,233 | $17.7M | 3.27% | Unchanged |
| ALMS Alumis Inc. | 4,247,670 | $17.5M | 3.24% | Unchanged |
| KYMR Kymera Therapeutics, Inc. | 146,332 | $16.9M | 3.11% | Unchanged |
| JBIO Jade Biosciences, Inc. | 886,667 | $13.6M | 2.50% | Unchanged |
| HNGE Hinge Health, Inc. | 108,100 | $11.5M | 2.13% | Reduced −51% |
| OBX Obsidian Therapeutics, Inc. | 916,063 | $10.9M | 2.02% | New |
| AURA Aura Biosciences, Inc. | 1,333,334 | $9.1M | 1.68% | Unchanged |
| BEAM Beam Therapeutics Inc. | 330,000 | $7.1M | 1.31% | Unchanged |
| AVBP ArriVent BioPharma, Inc. | 490,341 | $5.4M | 1.00% | Added +63% |
| IRON Disc Medicine, Inc. | 68,470 | $5.1M | 0.94% | Added +6,959% |
| NERV Minerva Neurosciences, Inc. | 1,985,584 | $4.1M | 0.76% | Unchanged |